Results 111 to 120 of about 489,113 (345)

Sudden Cardiac Death with Clozapine and Lorazepam Combination [PDF]

, 2012
Objective: To report a case of sudden cardiac death in a patient taking a combination of clozapine and lorazepam. Case summary: A 31-year-old white man with schizophrenia was found dead at his apartment.
Bhatia, Subhash C., Boust, Susan J., Petty, Frederick, Ramaswamy, Sriram, Sattar, Prizada S.   +4 more
core   +1 more source

Morte súbita e angina vasoespástica [PDF]

, 2002
Variant angina is defined by chest pain occurring at rest associated with transitory ST segment elevation on ECG, and is caused by a spasm of a coronary artery.
Andrea G Maria, Cacilda Dias Pereira, Claudio M Costa-Neto, Elaine Medeiros Floriano, Fernando Luiz De Lucca, João B Pesquero, Miriam G Jasiulionis, Patricia Dillenburg-Pilla, Rosana I Reis, Simone Gusmão Ramos   +9 more
core   +4 more sources

Tobacco smoking and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies

European Journal of Epidemiology, 2018
Smoking is an established risk factor for cardiovascular disease including coronary heart disease and stroke, however, data regarding smoking and sudden cardiac death have not been summarized in a meta-analysis previously.
D. Aune, S. Schlesinger, T. Norat, E. Riboli   +3 more
semanticscholar   +1 more source

Major Adverse Cardiac Events with Ondansetron: A Systematic Review

Clinical Pharmacology &Therapeutics, EarlyView.
Evidence base: 170 randomized trials, 23,421 adults, predominantly single‐dose IV ondansetron, mean follow‐up 20 days. Observed outcomes: Major adverse cardiac events were rare, no ventricular arrhythmias or torsades de pointes observed. Conclusion: Ondansetron was not associated with increased mortality or serious cardiac arrhythmias in adult ...
Michael Cristian Garcia, Bhavya Gandhi, Faisal Quadri, Mahnoor Shahab, Kassie Rong, Genevieve Ramnarine, Ishleen Sudan, Sophia Zhang, Michelle Yu, Sara Mojdehi, Lawrence Mbuagbaw, Anne M. Holbrook   +11 more
wiley   +1 more source

Mitochondrial DNA polymorphisms in individuals died from sudden cardiac death

Фундаментальная и клиническая медицина, 2019
Aim. To identify associations of mtDNA polymorphisms with sudden cardiac death.Materials and Methods. DNA was isolated from the cardiac tissue excised during the autopsy from individuals who died from sudden cardiac death (n = 260).
M. V. Golubenko, A. V. Tsepokina, R. R. Salakhov, V. N. Maksimov, A. A. Gurazheva, B. A. Tkhorenko, A. V. Ponasenko   +6 more
doaj   +1 more source

Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure) [PDF]

, 2017
Background—The risk of sudden cardiac death (SCD) in patients with heart failure following CABG has not been examined in a contemporary clinical trial of surgical revascularization. This analysis describes the incidence, timing and clinical predictors of
Al-Khatib, Sana M., Carson, Peter E., Cleland, John G.F., Desvigne-Nickens, Patrice M., Feldman, Arthur M., Lang, Irene M., Lee, Kerry L., Nicolau, Jose C., Pokorney, Sean, Rao, Meena P., Romanov, Alexander, Rouleau, Jean L., Selzman, Craig H., She, Lilin, Siepe, Matthias, Stepinska, Janina, Sueta, Carla, Tungsubutra, Wiwun, Velazquez, Eric J., Yii, Michael   +19 more
core   +2 more sources

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Brugada syndrome: 12 years of progression. [PDF]

, 2004
Brugada syndrome is increasingly being recognized in clinical medicine. What started as an electrocardiographic curiosity has become an important focus of attention for individuals working in the different disciplines related to sudden cardiac death ...
Antzelevitch, Charles, Brugada, Josep, Brugada, Pedro, Brugada, Ramon, Hong, Kui, Ohe, Tohru   +5 more
core   +1 more source